Ceruvia Lifesciences Appoints Stephen Hurst and David Steinberg to its Board of Directors
GREENWICH, Conn., Nov. 2, 2022 /PRNewswire/ -- Ceruvia Lifesciences, a leading neurotransformational biopharmaceutical company, is pleased to announce the appointment of Stephen Hurst and David
Source: finanznachrichten.de